Sort   by:  
 Page size 
UnknownA role for the class A penicillin-binding protein PonA2 in the survival of Mycobacterium smegmatis under conditions of nonreplication.
Not available
S-EPMC2901687 | biostudies-literature
UnknownPeptidoglycan synthesis in Mycobacterium tuberculosis is organized into networks with varying drug susceptibility.
Not available
S-EPMC4620856 | biostudies-literature
UnknownA cell wall synthase accelerates plasma membrane partitioning in mycobacteria.
Not available
S-EPMC10547480 | biostudies-literature
UnknownCorrelates between models of virulence for Mycobacterium tuberculosis among isolates of the Central Asian lineage: a case for lysozyme resistance testing?
Not available
S-EPMC4432750 | biostudies-literature
UnknownNovel C5α-substituted carbapenems enhance <i>Mycobacterium abscessus</i> killing via selective target binding and reduced hydrolysis by Bla<sub>Mab</sub>.
Not available
S-EPMC12326981 | biostudies-literature
UnknownFirst Penicillin-Binding Protein Occupancy Patterns for 15 β-Lactams and β-Lactamase Inhibitors in Mycobacterium abscessus.
Not available
S-EPMC7927833 | biostudies-literature
ProteomicsFirst penicillin-binding protein occupancy patterns for 15 β-lactams and β-lactamase inhibitors in Mycobacterium abscessus
Mycobacterium abscessus (Mab) causes serious infections that often require over 18 months of antibiotic combination therapy. With β lactam antibiotics being safe, double β-lactam and β-lactam/β-lactamase inhibitor combinations are of interest for improving treatment of Mab infections and minimizing ...
ORGANISM(S): Mycobacterium abscessus (strain ATCC 19977 / DSM 44196 / CIP 104536 / JCM 13569 / NCTC 13031 / TMC 1543) 
2020-11-24 | PXD022644 | Pride
Penicillin-binding proteins Beta-lactams Cell wall biosynthesis Pona2 Pona1 Pbpa Mycobacterium abscessus 
Sort   by:  
 Page size